𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Factors affecting the response of recurrent squamous cell carcinoma of the cervix to cisplatin

✍ Scribed by Mark E. Potter; Kenneth D. Hatch; Michelle Y. Potter; Hugh M. Shingleton; Vicki V. Baker

Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
341 KB
Volume
63
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Recurrent squamous cell carcinoma of the
Recurrent squamous cell carcinoma of the skin
✍ Steven C. Immerman; Edward F. Scanlon; Miriam Christ; Kerry L. Knox πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 378 KB πŸ‘ 1 views
Treatment of advanced and recurrent squa
Treatment of advanced and recurrent squamous carcinoma of the uterine cervix with constant intraarterial infusion of cisplatin
✍ Mark A. Rettenmaier; Mark F. Moran; Nilam F. Ramsinghani; Martin Colman; Nissar πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 351 KB πŸ‘ 1 views

Twelve patients with primary or locally recurrent squamous carcinoma of the cervix were treated with constant internal iliac artery infusion of cisplatin (CDDP) via a totally implantable chemotherapy pump. Seven previously untreated patients received standard external and interstitial radiotherapy (

Genetic alterations during the progressi
Genetic alterations during the progression of squamous cell carcinomas of the uterine cervix
✍ Anne-Marie F. Kersemaekers; Marc J. van de Vijver; Gemma G. Kenter; Gert Jan Fle πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 345 KB πŸ‘ 1 views

Most cervical carcinomas appear to arise from cervical intraepithelial neoplasia (CIN) lesions. In addition to infection with high-risk human papilloma viruses, which is indicative of an increased risk of progression, alterations of oncogenes and tumor suppressor genes play a role. Genetic studies o